Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Cristofanilli

Showing results (81-90 of 438) with videos related to

Pageof 44
Sort By:
The Oncologist|March 17, 2020
Hormone Receptor-Positive/Human Epidermal Growth Receptor 2-Negative Metastatic Breast Cancer in Young Women: Emerging Data in the Era of Molecularly Targeted AgentsAmi N Shah, Otto Metzger, Cynthia Huang Bartlett, et al.
Breast (Edinburgh, Scotland)|April 6, 2025
Mapping breast cancer therapy with circulating tumor cells: The expert perspectiveLorenzo Gerratana, Caterina Gianni, Eleonora Nicolò, et al.
The Breast Journal|March 19, 2009
Primary peritoneal serous carcinoma presenting as inflammatory breast cancerIbrahim Khalifeh, Michael T Deavers, Massimo Cristofanilli, et al.
Cancer|May 27, 2010
Differential regulation of the aggressive phenotype of inflammatory breast cancer cells by prostanoid receptors EP3 and EP4Fredika M Robertson, Ann-Marie Simeone, Anthony Lucci, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 3, 2014
AZD8931, an equipotent, reversible inhibitor of signaling by epidermal growth factor receptor (EGFR), HER2, and HER3: preclinical activity in HER2 non-amplified inflammatory breast cancer modelsZhaomei Mu, Teresa Klinowska, Xiaoshen Dong, et al.
The Oncologist|November 7, 2023
Circulating Tumor Cells Prediction in Hormone Receptor Positive HER2-Negative Advanced Breast Cancer: A Retrospective Analysis of the MONARCH 2 TrialLorenzo Gerratana, Masha Kocherginsky, Andrew A Davis, et al.
Cancer Treatment Reviews|July 12, 2023
The immunogram of inflammatory breast cancerCarmine Valenza, Dario Trapani, Nicola Fusco, et al.
Translational Oncology|October 27, 2015
A Preclinical Model of Inflammatory Breast Cancer to Study the Involvement of CXCR4 and ACKR3 in the Metastatic ProcessRoberto Wurth, Kevin Tarn, Danielle Jernigan, et al.
International Review of Cell and Molecular Biology|September 22, 2023
Latest advances in clinical studies of circulating tumor cells in early and metastatic breast cancerLaura S Munoz-Arcos, Eleonora Nicolò, Mara S Serafini, et al.
Radiology|March 29, 2008
Bone metastases in patients with metastatic breast cancer: morphologic and metabolic monitoring of response to systemic therapy with integrated PET/CTUkihide Tateishi, Cristina Gamez, Shaheenah Dawood, et al.
Pageof 44

Showing results (81-90 of 438) with videos related to

Sort By:
Pageof 44
The Oncologist|March 17, 2020
Hormone Receptor-Positive/Human Epidermal Growth Receptor 2-Negative Metastatic Breast Cancer in Young Women: Emerging Data in the Era of Molecularly Targeted AgentsAmi N Shah, Otto Metzger, Cynthia Huang Bartlett, et al.
Breast (Edinburgh, Scotland)|April 6, 2025
Mapping breast cancer therapy with circulating tumor cells: The expert perspectiveLorenzo Gerratana, Caterina Gianni, Eleonora Nicolò, et al.
The Breast Journal|March 19, 2009
Primary peritoneal serous carcinoma presenting as inflammatory breast cancerIbrahim Khalifeh, Michael T Deavers, Massimo Cristofanilli, et al.
Cancer|May 27, 2010
Differential regulation of the aggressive phenotype of inflammatory breast cancer cells by prostanoid receptors EP3 and EP4Fredika M Robertson, Ann-Marie Simeone, Anthony Lucci, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 3, 2014
AZD8931, an equipotent, reversible inhibitor of signaling by epidermal growth factor receptor (EGFR), HER2, and HER3: preclinical activity in HER2 non-amplified inflammatory breast cancer modelsZhaomei Mu, Teresa Klinowska, Xiaoshen Dong, et al.
The Oncologist|November 7, 2023
Circulating Tumor Cells Prediction in Hormone Receptor Positive HER2-Negative Advanced Breast Cancer: A Retrospective Analysis of the MONARCH 2 TrialLorenzo Gerratana, Masha Kocherginsky, Andrew A Davis, et al.
Cancer Treatment Reviews|July 12, 2023
The immunogram of inflammatory breast cancerCarmine Valenza, Dario Trapani, Nicola Fusco, et al.
Translational Oncology|October 27, 2015
A Preclinical Model of Inflammatory Breast Cancer to Study the Involvement of CXCR4 and ACKR3 in the Metastatic ProcessRoberto Wurth, Kevin Tarn, Danielle Jernigan, et al.
International Review of Cell and Molecular Biology|September 22, 2023
Latest advances in clinical studies of circulating tumor cells in early and metastatic breast cancerLaura S Munoz-Arcos, Eleonora Nicolò, Mara S Serafini, et al.
Radiology|March 29, 2008
Bone metastases in patients with metastatic breast cancer: morphologic and metabolic monitoring of response to systemic therapy with integrated PET/CTUkihide Tateishi, Cristina Gamez, Shaheenah Dawood, et al.
Pageof 44